Humans are the only known host of Bordetella pertussis.[2]Kilgore PE, Salim AM, Zervos MJ, et al. Pertussis: microbiology, disease, treatment, and prevention. Clin Microbiol Rev. 2016 Jul;29(3):449-86.
https://journals.asm.org/doi/10.1128/CMR.00083-15
http://www.ncbi.nlm.nih.gov/pubmed/27029594?tool=bestpractice.com
Pertussis is highly contagious, with up to 80% of susceptible household contacts developing clinical disease after exposure to an index case. Infection is transmitted person-to-person via respiratory droplets and airborne particles generated by coughing and sneezing or via fomites contaminated with respiratory secretions.[1]Havers FP, Moro PL, Hariri S, et al. Pertussis. In: Hall E, Wodi AP, Hamborsky J, et al, eds. Centers for Disease Control and Prevention. Epidemiology and prevention of vaccine-preventable diseases (the Pink Book). 14th ed. Washington, DC: Public Health Foundation; 2021. Updated Apr 2024.
https://www.cdc.gov/pinkbook/hcp/table-of-contents/chapter-16-pertussis.html
[2]Kilgore PE, Salim AM, Zervos MJ, et al. Pertussis: microbiology, disease, treatment, and prevention. Clin Microbiol Rev. 2016 Jul;29(3):449-86.
https://journals.asm.org/doi/10.1128/CMR.00083-15
http://www.ncbi.nlm.nih.gov/pubmed/27029594?tool=bestpractice.com
Transmission is most frequent in the first 1-2 weeks of infection; patients typically remain infectious for 2-3 weeks from the onset of cough if untreated. The incubation period is generally 7-10 days, with a range of 4-21 days.[1]Havers FP, Moro PL, Hariri S, et al. Pertussis. In: Hall E, Wodi AP, Hamborsky J, et al, eds. Centers for Disease Control and Prevention. Epidemiology and prevention of vaccine-preventable diseases (the Pink Book). 14th ed. Washington, DC: Public Health Foundation; 2021. Updated Apr 2024.
https://www.cdc.gov/pinkbook/hcp/table-of-contents/chapter-16-pertussis.html
[10]American Academy of Pediatrics. Red book 2024-2027: report of the committee on infectious diseases. May 2024 [internet publication].
https://publications.aap.org/redbook?autologincheck=redirected
Bacteria adhere to ciliated respiratory epithelial cells, where they produce toxins and other biologically active mediators, causing ciliary paralysis, local tissue damage, and inflammation.[4]Cherry JD. The 112-year odyssey of pertussis and pertussis vaccines - mistakes made and implications for the future. J Pediatric Infect Dis Soc. 2019 Sep 25;8(4):334-41.
https://academic.oup.com/jpids/article/8/4/334/5359449
http://www.ncbi.nlm.nih.gov/pubmed/30793754?tool=bestpractice.com
A characteristic lymphocytosis is caused by pertussis toxin. B pertussis can enter and survive within phagocytic leukocytes and non-phagocytic cells, but it is unclear how this affects the disease and the host immune response. B pertussis infection can result in a primary pertussis pneumonia. Bacteraemia does not occur. Infection elicits immune responses to a variety of bacterial antigens, but immunity is not permanent.[6]Cherry JD. Epidemic pertussis and acellular pertussis vaccine failure in the 21st century. Pediatrics. 2015 Jun;135(6):1130-2.
http://www.ncbi.nlm.nih.gov/pubmed/25941310?tool=bestpractice.com
[7]McGirr A, Fisman DN. Duration of pertussis immunity after DTaP immunization: a meta-analysis. Pediatrics. 2015 Feb;135(2):331-43.
http://www.ncbi.nlm.nih.gov/pubmed/25560446?tool=bestpractice.com
[11]Zerbo O, Bartlett J, Goddard K, et al. Acellular pertussis vaccine effectiveness over time. Pediatrics. 2019 Jul;144(1):e20183466.
https://publications.aap.org/pediatrics/article/144/1/e20183466/76822/Acellular-Pertussis-Vaccine-Effectiveness-Over
http://www.ncbi.nlm.nih.gov/pubmed/31182549?tool=bestpractice.com
[12]Vygen-Bonnet S, Hellenbrand W, Garbe E, et al. Safety and effectiveness of acellular pertussis vaccination during pregnancy: a systematic review. BMC Infect Dis. 2020 Feb 13;20(1):136.
https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-020-4824-3
http://www.ncbi.nlm.nih.gov/pubmed/32054444?tool=bestpractice.com